Previous studies in T-cell lymphoma showed a link between poor prognosis and MYCBP2 overexpression, indicating the involvement of MYCBP2 in cancer.38 Using in silico analysis of publicly available mRNA microarray datasets, we found higher MYCBP2 mRNA levels correlate with worse survival in CRC (Fig. 6f). Here, MYCBP2 is linked to T-cell non-Hodgkin lymphoma.